Intrahepatic levels of microbiome-derived hippurate associates with improved metabolic dysfunction-associated steatotic liver disease.
Deslande M, Puig-Castellvi F, Castro-Dionicio I, Pacheco-Tapia R, Raverdy V, Caiazzo R, Lassailly G, Leloire A, Andrikopoulos P, Kahoul Y, Zaïbi N, Toussaint B, Oger F, Gambardella N, Lefebvre P, Derhourhi M, Amanzougarene S, Staels B, Pattou F, Froguel P, Bonnefond A, Dumas ME.
Deslande M, et al. Among authors: lefebvre p.
Mol Metab. 2024 Dec 31;92:102090. doi: 10.1016/j.molmet.2024.102090. Online ahead of print.
Mol Metab. 2024.
PMID: 39746606
Free article.